Applications of Nanotherapeutics and Nanotheranostics in Managing Infectious Diseases
portes grátis
Applications of Nanotherapeutics and Nanotheranostics in Managing Infectious Diseases
Parashar, Poonam; Kumar, Anoop
Elsevier Science Publishing Co Inc
02/2025
690
Mole
Inglês
9780443288364
15 a 20 dias
Descrição não disponível.
INTRODUCTION
1. The Pursuit of Nanotherapeutics: Drug Delivery, Recent Advances, and Future Perspectives
2. An Overview of Nanotherapeutics and Nanodiagnostics
3. Nanotherapeutics Impregnated Medical Devices and Their Regulatory Aspects
4. Nanotherapeutics as Vaccines and Their Regulatory Aspect
APPLICATIONS OF NANOTHERAPEUTICS AND NANOTHERANOSTICS IN BACTERIAL INFECTIONS
5. Pulmonary Infections
6. Gastric Infections
7. Skin and Soft Tissue Infections
8. Wound Infections Including Diabetic Foot
9. Ocular Infections
10. Bone Infections
11. Tuberculosis - Pulmonary and Extrapulmonary
12. Nanotherapeutics Against Bacterial Biofilms
13. Nanotherapeutics Against Drug-Resistant Pathogens
14. Miscellaneous Bacterial Infections
APPLICATIONS OF NANOTHERAPEUTICS AND NANOTHERANOSTICS IN VIRAL INFECTIONS
15. Human Immunodeficiency Viruses (HIV) Infections
16. Covid-19 and Associated Pulmonary Infections
17. Japanese Encephalitis Virus (JEV) Infections
18. Miscellaneous Viral Infections
APPLICATIONS OF NANOTHERAPEUTICS AND NANOTHERANOSTICS IN FUNGAL INFESTATIONS
19. Nanotherapeutics in Candidiasis
20. Nanotherapeutics Miscellaneous Fungal Infections (Aspergillosis, Mucormycosis, Etc).
APPLICATIONS OF NANOTHERAPEUTICS AND NANOTHERANOSTICS IN PARASITIC INFESTATIONS
21. Nanotherapeutics in Malaria
22. Nanotherapeutics in Leishmaniasis
APPLICATIONS OF NANOTHERAPEUTICS AND NANOTHERANOSTICS IN MISCELLANEOUS INFESTATIONS
23. Cancer-Associated Infections
24. Septicemia
25. Trueperella Pyogenes Infection
26. Metabolic Diseases Associated Infections
27. Pharmacokinetics of Nanoparticles for Infectious Diseases
1. The Pursuit of Nanotherapeutics: Drug Delivery, Recent Advances, and Future Perspectives
2. An Overview of Nanotherapeutics and Nanodiagnostics
3. Nanotherapeutics Impregnated Medical Devices and Their Regulatory Aspects
4. Nanotherapeutics as Vaccines and Their Regulatory Aspect
APPLICATIONS OF NANOTHERAPEUTICS AND NANOTHERANOSTICS IN BACTERIAL INFECTIONS
5. Pulmonary Infections
6. Gastric Infections
7. Skin and Soft Tissue Infections
8. Wound Infections Including Diabetic Foot
9. Ocular Infections
10. Bone Infections
11. Tuberculosis - Pulmonary and Extrapulmonary
12. Nanotherapeutics Against Bacterial Biofilms
13. Nanotherapeutics Against Drug-Resistant Pathogens
14. Miscellaneous Bacterial Infections
APPLICATIONS OF NANOTHERAPEUTICS AND NANOTHERANOSTICS IN VIRAL INFECTIONS
15. Human Immunodeficiency Viruses (HIV) Infections
16. Covid-19 and Associated Pulmonary Infections
17. Japanese Encephalitis Virus (JEV) Infections
18. Miscellaneous Viral Infections
APPLICATIONS OF NANOTHERAPEUTICS AND NANOTHERANOSTICS IN FUNGAL INFESTATIONS
19. Nanotherapeutics in Candidiasis
20. Nanotherapeutics Miscellaneous Fungal Infections (Aspergillosis, Mucormycosis, Etc).
APPLICATIONS OF NANOTHERAPEUTICS AND NANOTHERANOSTICS IN PARASITIC INFESTATIONS
21. Nanotherapeutics in Malaria
22. Nanotherapeutics in Leishmaniasis
APPLICATIONS OF NANOTHERAPEUTICS AND NANOTHERANOSTICS IN MISCELLANEOUS INFESTATIONS
23. Cancer-Associated Infections
24. Septicemia
25. Trueperella Pyogenes Infection
26. Metabolic Diseases Associated Infections
27. Pharmacokinetics of Nanoparticles for Infectious Diseases
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Animal science; Antibiotic resistance; Antibiotic; Antibiotic-resistant microorganisms; Antibiotics; Antifungal; Antiinflammatory; Antimalarial drugs; Antimicrobial; Antiretroviral therapy; Antiviral agents; Antiviral drugs; Bacterial infection; Bacterial infections; Bioavailability; Biocompatibility; Biofilm; Biological barriers; Bone infection; Cancer; Candidiasis; Carrier system; Cellular process; Clinical applications; Clinical trials; Conventional dosage forms; COVID-19Drug delivery system; Cutaneous leishmaniasis; Diagnosis; Diagnostic tools; Diagnostics; Drug delivery system; Drug delivery; Drug resistance; Drug targeting; Effectiveness; Epstein-Barr virus; Extracellular vesicles; Extrapulmonary tuberculosis; Gastric cancer; Gene therapy; Giardia duodenalis; Gold nanoparticle; Green synthesis; Gut-lung axis; Helicobacter pylori; Herpes virus; Human immunodeficiency virus; Hybrid nano-based systems; Hydrogels; Imaging; Immune response; Infections; Infectious disease; Infectious diseases; Infectious; Influenza virus; Japanese encephalitis virus; Leishmaniasis; Liposomal lipid nanoparticle; Liposomes; Lipotomes; Lung infection; Malaria; Materials in biotechnology; Medical devices; Metal nanoparticles; Microbes; Microbiota; Modified drug release; Mucocutaneous leishmaniasis nanotherapeutics; Mycobacterium tuberculosis; Nano-based technologies; Nanocarriers; Nanoclay; Nanodiagnostics; Nanofibers; Nanoflower; Nanoformulations; Nano-magic; Nanomaterial; Nanomaterials; Nanomedicine; Nanoparticles; Nanoplates; Nanostructured lipid carriers; Nanotechnologies; Nanotechnology; Nanotheranostic; Nanotheranostics; Nanotherapeutics; Nanovaccines; Neurotherapeutic; Ocular disease; Ophthalmic medication; Ophthalmic medications; Patent; Pathogens; Pharmaceutical preparation; Pharmaceutical therapy; Pharmaceutics COVID-19 and associated pulmonary infections; Pharmaceutics; Pharmacodynamics; Pharmacokinetics; Pharmacological parameter; Precision medicine; Probiotics; Public health; Pulmonary tuberculosis; Pulmonary; Reepithelization; Respiratory disorders; Respiratory system disease; Sepsis; Septicemia; Silver nanoparticle; siRNA-based nanoparticles; Solid lipid nanoparticles; Syndrome X; Targeted delivery; Targeted drug; Targeted therapy; Targeting; Theranostics; Therapeutics; Tissue engineering; Trueperella pyogenes; Tuberculosis; Vaccine; Vaccines; Viral reservoirs; Visceral leishmaniasis; Wound
INTRODUCTION
1. The Pursuit of Nanotherapeutics: Drug Delivery, Recent Advances, and Future Perspectives
2. An Overview of Nanotherapeutics and Nanodiagnostics
3. Nanotherapeutics Impregnated Medical Devices and Their Regulatory Aspects
4. Nanotherapeutics as Vaccines and Their Regulatory Aspect
APPLICATIONS OF NANOTHERAPEUTICS AND NANOTHERANOSTICS IN BACTERIAL INFECTIONS
5. Pulmonary Infections
6. Gastric Infections
7. Skin and Soft Tissue Infections
8. Wound Infections Including Diabetic Foot
9. Ocular Infections
10. Bone Infections
11. Tuberculosis - Pulmonary and Extrapulmonary
12. Nanotherapeutics Against Bacterial Biofilms
13. Nanotherapeutics Against Drug-Resistant Pathogens
14. Miscellaneous Bacterial Infections
APPLICATIONS OF NANOTHERAPEUTICS AND NANOTHERANOSTICS IN VIRAL INFECTIONS
15. Human Immunodeficiency Viruses (HIV) Infections
16. Covid-19 and Associated Pulmonary Infections
17. Japanese Encephalitis Virus (JEV) Infections
18. Miscellaneous Viral Infections
APPLICATIONS OF NANOTHERAPEUTICS AND NANOTHERANOSTICS IN FUNGAL INFESTATIONS
19. Nanotherapeutics in Candidiasis
20. Nanotherapeutics Miscellaneous Fungal Infections (Aspergillosis, Mucormycosis, Etc).
APPLICATIONS OF NANOTHERAPEUTICS AND NANOTHERANOSTICS IN PARASITIC INFESTATIONS
21. Nanotherapeutics in Malaria
22. Nanotherapeutics in Leishmaniasis
APPLICATIONS OF NANOTHERAPEUTICS AND NANOTHERANOSTICS IN MISCELLANEOUS INFESTATIONS
23. Cancer-Associated Infections
24. Septicemia
25. Trueperella Pyogenes Infection
26. Metabolic Diseases Associated Infections
27. Pharmacokinetics of Nanoparticles for Infectious Diseases
1. The Pursuit of Nanotherapeutics: Drug Delivery, Recent Advances, and Future Perspectives
2. An Overview of Nanotherapeutics and Nanodiagnostics
3. Nanotherapeutics Impregnated Medical Devices and Their Regulatory Aspects
4. Nanotherapeutics as Vaccines and Their Regulatory Aspect
APPLICATIONS OF NANOTHERAPEUTICS AND NANOTHERANOSTICS IN BACTERIAL INFECTIONS
5. Pulmonary Infections
6. Gastric Infections
7. Skin and Soft Tissue Infections
8. Wound Infections Including Diabetic Foot
9. Ocular Infections
10. Bone Infections
11. Tuberculosis - Pulmonary and Extrapulmonary
12. Nanotherapeutics Against Bacterial Biofilms
13. Nanotherapeutics Against Drug-Resistant Pathogens
14. Miscellaneous Bacterial Infections
APPLICATIONS OF NANOTHERAPEUTICS AND NANOTHERANOSTICS IN VIRAL INFECTIONS
15. Human Immunodeficiency Viruses (HIV) Infections
16. Covid-19 and Associated Pulmonary Infections
17. Japanese Encephalitis Virus (JEV) Infections
18. Miscellaneous Viral Infections
APPLICATIONS OF NANOTHERAPEUTICS AND NANOTHERANOSTICS IN FUNGAL INFESTATIONS
19. Nanotherapeutics in Candidiasis
20. Nanotherapeutics Miscellaneous Fungal Infections (Aspergillosis, Mucormycosis, Etc).
APPLICATIONS OF NANOTHERAPEUTICS AND NANOTHERANOSTICS IN PARASITIC INFESTATIONS
21. Nanotherapeutics in Malaria
22. Nanotherapeutics in Leishmaniasis
APPLICATIONS OF NANOTHERAPEUTICS AND NANOTHERANOSTICS IN MISCELLANEOUS INFESTATIONS
23. Cancer-Associated Infections
24. Septicemia
25. Trueperella Pyogenes Infection
26. Metabolic Diseases Associated Infections
27. Pharmacokinetics of Nanoparticles for Infectious Diseases
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Animal science; Antibiotic resistance; Antibiotic; Antibiotic-resistant microorganisms; Antibiotics; Antifungal; Antiinflammatory; Antimalarial drugs; Antimicrobial; Antiretroviral therapy; Antiviral agents; Antiviral drugs; Bacterial infection; Bacterial infections; Bioavailability; Biocompatibility; Biofilm; Biological barriers; Bone infection; Cancer; Candidiasis; Carrier system; Cellular process; Clinical applications; Clinical trials; Conventional dosage forms; COVID-19Drug delivery system; Cutaneous leishmaniasis; Diagnosis; Diagnostic tools; Diagnostics; Drug delivery system; Drug delivery; Drug resistance; Drug targeting; Effectiveness; Epstein-Barr virus; Extracellular vesicles; Extrapulmonary tuberculosis; Gastric cancer; Gene therapy; Giardia duodenalis; Gold nanoparticle; Green synthesis; Gut-lung axis; Helicobacter pylori; Herpes virus; Human immunodeficiency virus; Hybrid nano-based systems; Hydrogels; Imaging; Immune response; Infections; Infectious disease; Infectious diseases; Infectious; Influenza virus; Japanese encephalitis virus; Leishmaniasis; Liposomal lipid nanoparticle; Liposomes; Lipotomes; Lung infection; Malaria; Materials in biotechnology; Medical devices; Metal nanoparticles; Microbes; Microbiota; Modified drug release; Mucocutaneous leishmaniasis nanotherapeutics; Mycobacterium tuberculosis; Nano-based technologies; Nanocarriers; Nanoclay; Nanodiagnostics; Nanofibers; Nanoflower; Nanoformulations; Nano-magic; Nanomaterial; Nanomaterials; Nanomedicine; Nanoparticles; Nanoplates; Nanostructured lipid carriers; Nanotechnologies; Nanotechnology; Nanotheranostic; Nanotheranostics; Nanotherapeutics; Nanovaccines; Neurotherapeutic; Ocular disease; Ophthalmic medication; Ophthalmic medications; Patent; Pathogens; Pharmaceutical preparation; Pharmaceutical therapy; Pharmaceutics COVID-19 and associated pulmonary infections; Pharmaceutics; Pharmacodynamics; Pharmacokinetics; Pharmacological parameter; Precision medicine; Probiotics; Public health; Pulmonary tuberculosis; Pulmonary; Reepithelization; Respiratory disorders; Respiratory system disease; Sepsis; Septicemia; Silver nanoparticle; siRNA-based nanoparticles; Solid lipid nanoparticles; Syndrome X; Targeted delivery; Targeted drug; Targeted therapy; Targeting; Theranostics; Therapeutics; Tissue engineering; Trueperella pyogenes; Tuberculosis; Vaccine; Vaccines; Viral reservoirs; Visceral leishmaniasis; Wound
